Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. 6. Juni 2013 van de Water, W., Seynaeve, C., Bastiaannet, E., Markopoulos, C., Jones, S.E., Rea, D., Hasenburg, A., Putter, H., Hille, E.T.M., Paridaens, R., de Craen, A.J.M., Westendorp, R.G.J., van de Velde, C.J.H., Liefers, G.-J., 2013. Oncologist 18, 8–13. doi:10.1634/theoncologist.2012-0315 Abstract Overall survival and sequential treatment of patients with metastatic breast cancer treated by German office-based medical oncologists – outcome data from the TMK Registry. Tesch, H., Däßler, K., Müller-Hagen, S., Kruggel, L., Jänicke, M., Marschner, N., 2013. Onkologie 36 (suppl 7)(V358), 98. doi:10.1159/000356365 Abstract… Weiterlesen Efficacy and Safety of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS, Int-2 or High Risk), AML (WHO 20-30% Blasts), or CMMoL (10-29% Bone Marrow Blasts Without Myeloproliferative Disorder): First interim analysis of the non-interventional study PIAZA. Wehmeyer, J., Zaiss, M., Losem, C., Schmitz, S., Teichmann, B., Harde, J., Hasskarl, J., 2013. Onkologie 36 (suppl. 7)(P797), 241. doi:10.1159/000356365… Weiterlesen